Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer

We've built an unbiased platform that lets data drive decisions, not us, says Recursion CEOПодробнее

Jim Cramer looks at Nvidia's surge despite the market downturnПодробнее

Recursion CEO Chris Gibson: There's real opportunity to leverage A.I. to speed up drug developmentПодробнее

Williams-Sonoma CEO Laura Alber goes one-on-one with Jim CramerПодробнее

Jim Cramer: Nvidia shares can go even higherПодробнее

Nvidia is simply much bigger than a semiconductor company, says Jim CramerПодробнее

Nvidia CEO Jensen Huang goes one-on-one with Jim CramerПодробнее

'We look like what the future of all biopharma companies will look like', says Recursion CEO GibsonПодробнее

Snowflake CEO joins Jim Cramer after earnings report drives stock higherПодробнее

I think Nvidia sees us as a leader of this new space of AI-driven biotech: Recursion CEOПодробнее

Jim Cramer on Deckers Outdoor reaching $1000 a share: Nobody can touch them right nowПодробнее

CCM Patient Conference 2023 - Keynote Speech by Recursion CEO & Co-founder Chris GibsonПодробнее

Founder Stories: Chris Gibson, Co-Founder and CEO of Recursion PharmaceuticalsПодробнее

Download Day 2023 — State of Drug Discovery & State of Recursion by Chris Gibson, Co-founder & CEOПодробнее

Jim Cramer takes a look at Macy's after strong 1Q earningsПодробнее

Lightning Round: I would not be a buyer of Corning all the way up here, says Jim CramerПодробнее

We expect earnings near the top end of our range, say Charles Schwab CEO BettingerПодробнее

Jim Cramer looks at how the Fed minutes spooked the markets todayПодробнее